102914606
commented on
Investors believe JanOne's strong revenue growth may underperform the industry, accepting a low P/S ratio. The recent share price surge wasn't enough to reach industry median, and future revenue is unlikely to surprise positively. If medium-term revenue trends persist, share price reversal seems unlikely.
1
$AGBA Group(AGBA.US$ Slight profit taking is good for further uptrend.
$SuperCom(SPCB.US$ It's still cheap, not yet finish.
1
3
$Beneficient(BENF.US$ It will be another trap stock for short.... we'll see next week.
$Collective Audience(CAUD.US$ Buy this now and keep, it will rebound probably . I observed big volumes buying at 0.75-0.80 in pre-market. It just a matter of time. I'm loading more when it drops below 0.60.
102914606
commented on
1
1
$MSP Recovery(LIFW.US$ Very soon it will rise to 2 dollars.
3
102914606
commented on
$Aesthetic Medical International(AIH.US$ It needs some more volumes in order to push it. If not, the shorts can easily suppress the buyers. Post market the volumes seem ok but Pre-market still lagging a bit. Maybe later will be better when peoples go home after work.
1
8
102914606 : Although the revenue growth increases, their losses also increase significantly. It will only be worth buying unless they are can break even this year.